GSK

GSK

featured image of GSK's $50m Acquisition Revolutionizes Oligonucleotide Drug Development
Companies

GSK’s $50m Acquisition Revolutionizes Oligonucleotide Drug Development

BIOT

📢 GSK acquires Elsie Biotechnologies in a $50m deal to enhance its drug platform and develop treatments for difficult-to-treat diseases. 🧬👥🚀

featured image of Breakthrough Partnership: GSK and Elegen Revolutionize DNA Medicines
Companies

Breakthrough Partnership: GSK and Elegen Revolutionize DNA Medicines

BIOT

🔬 GSK teams up with Elegen Bio to develop DNA-based medicines and vaccines, revolutionizing the field of biotechnology. 💉💊

featured image of Game-Changing Respiratory Breakthrough: GSK's $14bn Aiolos Bio Acquisition!
Companies

Game-Changing Respiratory Breakthrough: GSK’s $14bn Aiolos Bio Acquisition!

BIOT

📢 GSK breathes new life into its respiratory pipeline with $1.4bn Aiolos Bio acquisition, reinforcing commitment to patients worldwide. 😷💊🌍

Bioprocessupdates

©2023 - 2026 BioprocessUpdates

PRIVACY POLICY terms of service contact